3-iodo-alpha-methyltyrosine has been researched along with Sarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Vries, EG; Hoekstra, HJ; Jager, PL; Molenaar, WM; Piers, DA; Plaat, BE; Vaalburg, W | 1 |
1 other study(ies) available for 3-iodo-alpha-methyltyrosine and Sarcoma
| Article | Year |
|---|---|
Imaging of soft-tissue tumors using L-3-[iodine-123]iodo-alpha-methyl-tyrosine single photon emission computed tomography: comparison with proliferative and mitotic activity, cellularity, and vascularity.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cell Division; Female; Humans; Ki-67 Antigen; Male; Methyltyrosines; Middle Aged; Mitosis; Neoplasm Metastasis; Neovascularization, Pathologic; Sarcoma; Soft Tissue Neoplasms; Time Factors; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |